224 related articles for article (PubMed ID: 19747494)
1. Swim stress enhances nociceptin/orphanin FQ-induced inhibition of rat dorsal raphe nucleus activity in vivo and in vitro: role of corticotropin releasing factor.
Nazzaro C; Barbieri M; Varani K; Beani L; Valentino RJ; Siniscalchi A
Neuropharmacology; 2010 Feb; 58(2):457-64. PubMed ID: 19747494
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of serotonin outflow by nociceptin/orphaninFQ in dorsal raphe nucleus slices from normal and stressed rats: Role of corticotropin releasing factor.
Nazzaro C; Marino S; Barbieri M; Siniscalchi A
Neurochem Int; 2009; 54(5-6):378-84. PubMed ID: 19418633
[TBL] [Abstract][Full Text] [Related]
3. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons.
Kirby LG; Freeman-Daniels E; Lemos JC; Nunan JD; Lamy C; Akanwa A; Beck SG
J Neurosci; 2008 Nov; 28(48):12927-37. PubMed ID: 19036986
[TBL] [Abstract][Full Text] [Related]
5. Acute and subchronic treatments with selective serotonin reuptake inhibitors increase Nociceptin/Orphanin FQ (NOP) receptor density in the rat dorsal raphe nucleus; interactions between nociceptin/NOP system and serotonin.
Le Maître E; Dourmap N; Vilpoux C; Leborgne R; Janin F; Bonnet JJ; Costentin J; Leroux-Nicollet I
Brain Res; 2013 Jul; 1520():51-60. PubMed ID: 23669068
[TBL] [Abstract][Full Text] [Related]
6. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs.
Gavioli EC; Calo' G
Pharmacol Ther; 2013 Oct; 140(1):10-25. PubMed ID: 23711793
[TBL] [Abstract][Full Text] [Related]
7. Swim stress differentially blocks CRF receptor mediated responses in dorsal raphe nucleus.
Lamy CM; Beck SG
Psychoneuroendocrinology; 2010 Oct; 35(9):1321-32. PubMed ID: 20399020
[TBL] [Abstract][Full Text] [Related]
8. CRF-5-HT interactions in the dorsal raphe nucleus and motivation for stress-induced opioid reinstatement.
Li C; McCloskey N; Phillips J; Simmons SJ; Kirby LG
Psychopharmacology (Berl); 2021 Jan; 238(1):29-40. PubMed ID: 33231727
[TBL] [Abstract][Full Text] [Related]
9. Nociceptin/orphanin FQ blockade of corticotropin-releasing factor-induced gamma-aminobutyric acid release in central amygdala is enhanced after chronic ethanol exposure.
Cruz MT; Herman MA; Kallupi M; Roberto M
Biol Psychiatry; 2012 Apr; 71(8):666-76. PubMed ID: 22153590
[TBL] [Abstract][Full Text] [Related]
10. Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus.
Kirby LG; Rice KC; Valentino RJ
Neuropsychopharmacology; 2000 Feb; 22(2):148-62. PubMed ID: 10649828
[TBL] [Abstract][Full Text] [Related]
11. Nociceptin/orphanin FQ decreases serotonin efflux in the rat brain but in contrast to a kappa-opioid has no antagonistic effect on mu-opioid-induced increases in serotonin efflux.
Tao R; Ma Z; Thakkar MM; McCarley RW; Auerbach SB
Neuroscience; 2007 Jun; 147(1):106-16. PubMed ID: 17499930
[TBL] [Abstract][Full Text] [Related]
12. Actions of orphanin FQ/nociceptin on rat ventral tegmental area neurons in vitro.
Zheng F; Grandy DK; Johnson SW
Br J Pharmacol; 2002 Aug; 136(7):1065-71. PubMed ID: 12145107
[TBL] [Abstract][Full Text] [Related]
13. Effect of lamotrigine and carbamazepine on corticotropin-releasing factor-associated serotonergic transmission in rat dorsal raphe nucleus.
Tanahashi S; Yamamura S; Nakagawa M; Motomura E; Okada M
Psychopharmacology (Berl); 2012 Apr; 220(3):599-610. PubMed ID: 21947356
[TBL] [Abstract][Full Text] [Related]
14. The nociceptin receptor antagonist [Nphe1,Arg14,Lys15]nociceptin/orphanin FQ-NH2 blocks the stimulatory effects of nociceptin/orphanin FQ on the HPA axis in rats.
Leggett JD; Harbuz MS; Jessop DS; Fulford AJ
Neuroscience; 2006 Sep; 141(4):2051-7. PubMed ID: 16784820
[TBL] [Abstract][Full Text] [Related]
15. Actions of nociceptin/orphanin FQ and other prepronociceptin products on rat rostral ventromedial medulla neurons in vitro.
Vaughan CW; Connor M; Jennings EA; Marinelli S; Allen RG; Christie MJ
J Physiol; 2001 Aug; 534(Pt 3):849-59. PubMed ID: 11483714
[TBL] [Abstract][Full Text] [Related]
16. Orphanin FQ produces gender-specific modulation of trigeminal nociception: behavioral and electrophysiological observations.
Flores CA; Wang XM; Zhang KM; Mokha SS
Neuroscience; 2001; 105(2):489-98. PubMed ID: 11672614
[TBL] [Abstract][Full Text] [Related]
17. [Nphe1,Arg14,Lys15]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor.
Calo G; Rizzi A; Rizzi D; Bigoni R; Guerrini R; Marzola G; Marti M; McDonald J; Morari M; Lambert DG; Salvadori S; Regoli D
Br J Pharmacol; 2002 May; 136(2):303-11. PubMed ID: 12010780
[TBL] [Abstract][Full Text] [Related]
18. The bed nucleus is a neuroanatomical substrate for the anorectic effect of corticotropin-releasing factor and for its reversal by nociceptin/orphanin FQ.
Ciccocioppo R; Fedeli A; Economidou D; Policani F; Weiss F; Massi M
J Neurosci; 2003 Oct; 23(28):9445-51. PubMed ID: 14561874
[TBL] [Abstract][Full Text] [Related]
19. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
Chiou LC; Chuang KC; Wichmann J; Adam G
J Pharmacol Exp Ther; 2004 Nov; 311(2):645-51. PubMed ID: 15254141
[TBL] [Abstract][Full Text] [Related]
20. Restraint stress alters nociceptin/orphanin FQ and CRF systems in the rat central amygdala: significance for anxiety-like behaviors.
Ciccocioppo R; de Guglielmo G; Hansson AC; Ubaldi M; Kallupi M; Cruz MT; Oleata CS; Heilig M; Roberto M
J Neurosci; 2014 Jan; 34(2):363-72. PubMed ID: 24403138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
